Serum Infliximab Trough Levels Above 1.0 Mg/mL Are Required to Obtain Clinical Efficacy in Patients With Crohnʼs Disease
Imaeda, Hirotsugu, Andoh, Akira, Takahashi, Kenichiro, Fujimoto, Takehide, Ban, Hiromitsu, Bamba, Shigeki, Fujiyama, YoshihideVolume:
18
Language:
english
Journal:
Inflammatory Bowel Diseases
DOI:
10.1097/00054725-201212001-00146
Date:
December, 2012
File:
PDF, 675 KB
english, 2012